Drapkin Kimberlee C
- SEC CIK
- 0001340881
No open-market purchases or sales filed in the past year.
Current role at each company
- LENZ LENZ Therapeutics, Inc.Directoras of Jun 15, 2026
- CLYM Climb Bio, Inc.Directoras of Jun 8, 2026
- ABOS Acumen Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- KA Kineta, Inc.Directoras of Jul 2, 2025
- JNCE Jounce Therapeutics, Inc.President, CFO and Treasureras of May 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Drapkin Kimberlee C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JNCE Jounce Therapeutics, Inc.
President, CFO and Treasurer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 (view filing) | Jan 9-10 | 2 days | Drapkin Kimberlee CCFO and Treasurer | SSale | −14.1K | $1.11 | −$15.7K | −17.6%66.0K after | 2 lots |
| Jan 11, 2022 (view filing) | Jan 7-10 | 4 days | Drapkin Kimberlee CCFO and Treasurer | SSale | −12.8K | $6.88 | −$88.2K | −19.6%52.6K after | 2 lots |